Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

5D-QSAR: the key for simulating induced fit?

Angelo Vedani1, Max Dobler

  • 1Biographics Laboratory 3R, Friedensgasse 35, CH-4056 Basel, Switzerland. admin@biograf.ch

Journal of Medicinal Chemistry
|May 17, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Profiling withanolide A for therapeutic targets in neurodegenerative diseases.

Bioorganic & medicinal chemistry·2019
Same author

In Silico Prediction of the Toxic Potential of Lupeol.

Chemical research in toxicology·2017
Same author

Probing Small-Molecule Binding to the Liver-X Receptor: A Mixed-Model QSAR Study.

Molecular informatics·2016
Same author

VirtualToxLab: Exploring the Toxic Potential of Rejuvenating Substances Found in Traditional Medicines.

Methods in molecular biology (Clifton, N.J.)·2016
Same author

Molecular mechanisms of endocrine and metabolic disruption: An in silico study on antitrypanosomal natural products and some derivatives.

Toxicology letters·2016
Same author

OpenVirtualToxLab--a platform for generating and exchanging in silico toxicity data.

Toxicology letters·2014
Same journal

Development of Indole-3-yl-methylene-thiobarbital Derivatives as Inhibitors of HDAC8 Enzyme Activity.

Journal of medicinal chemistry·2026
Same journal

Discovery of a Potent NAMPT-Targeting PROTAC for the Suppression of Triple-Negative Breast Cancer via Macrophage Reprogramming.

Journal of medicinal chemistry·2026
Same journal

3',4'-Isopropylidene-α-galactosylceramide Enables Multidose Th1 Adjuvanticity Despite Limited Serial Serum IFN-γ Responsiveness.

Journal of medicinal chemistry·2026
Same journal

A Bioorthogonally Cleavable <i>N</i>-Oxide Linker for Prodrug Design: Elucidating the Structure-Cyclization Kinetics Relationships for Controlled Drug Release.

Journal of medicinal chemistry·2026
Same journal

A Melatonin-Catechol Hybrid Molecule Prolongs Lifespan via Regulating ROS and Reprogramming Mitochondrial Metabolism.

Journal of medicinal chemistry·2026
Same journal

Discovery of SD-2301 as a Highly Potent and Selective PROTAC STAT3 Degrader Capable of Achieving Complete Tumor Regression with Single Administration.

Journal of medicinal chemistry·2026
See all related articles

We introduce 5D-QSAR, an advancement over 4D-QSAR, by incorporating receptor flexibility. This method reduces bias and improves prediction accuracy for drug discovery by considering multiple receptor states.

Area of Science:

  • Computational Chemistry
  • Cheminformatics
  • Drug Discovery

Background:

  • Four-dimensional quantitative structure-activity relationship (4D-QSAR) models reduce bias by accounting for ligand conformation, orientation, and protonation.
  • A limitation of 4D-QSAR is the need for a priori assumptions about receptor binding pocket adaptation (induced fit).

Purpose of the Study:

  • To extend the 4D-QSAR concept by incorporating receptor flexibility, creating a five-dimensional quantitative structure-activity relationship (5D-QSAR) approach.
  • To reduce bias in QSAR modeling by allowing multiple representations of the receptor binding site topology.

Main Methods:

  • Development and application of the 5D-QSAR method, implemented in the Quasar software.
  • Simulation of multiple receptor-induced fit protocols to generate a diverse set of receptor surrogate topologies.

Related Experiment Videos

  • Comparison of 5D-QSAR with 4D-QSAR using neurokinin-1 (NK-1) and aryl hydrocarbon (Ah) receptor systems.

    • Main Results:

    • 5D-QSAR demonstrated convergence to a single model despite exploring multiple receptor topologies, yielding less biased results than 4D-QSAR.
    • For the NK-1 receptor system, 5D-QSAR achieved a cross-validated r² of 0.870 and predictive r² of 0.837.
    • For the Ah receptor system, 5D-QSAR achieved a cross-validated r² of 0.838 and predictive r² of 0.832.

    Conclusions:

    • The 5D-QSAR approach provides less biased boundary conditions and healthier model populations compared to 4D-QSAR.
    • The increased computational investment in 5D-QSAR leads to more accurate predictions of new compounds.
    • 5D-QSAR represents a significant advancement for predictive modeling in drug discovery.